The COVID-19 Pandemic – News and Features
Chromatography in the Vaccine Pipeline
As vaccine technologies evolve, sophisticated analytical tools are needed to support vaccine discovery, development and manufacturing. In this article, we explore the role of chromatography in the vaccine pipeline.
Why Do Some Vaccines Create Long-Lived Responses? Ask the Researcher
In this Ask the Researcher, we spoke with Professor David Tarlinton to learn more about long-lived plasma cells; how they are made and how they are stored.
Novel Device Detects COVID-19 Antibodies in Five Minutes
Scientists have developed an electrochemical immunosensor that rapidly detects antibodies against SARS-CoV-2.
Advances and New Technologies in Syndromic Testing
Technology Networks spoke with Arvind Kothandaraman to find out about the technologies underpinning syndromic testing, recent advances in the field and its possible role in pandemic prevention.
Vaccine Tablet Prevents UTIs in Mice
A vaccine tablet has been designed that dissolves when placed under the tongue, allowing mucus-penetrating nanofibers that contain E. coli proteins to enter the body and produce an immune response, preventing UTIs.
Synthetic DNA Can Control Cells’ Protein Production
Artificial intelligence has helped researchers to design synthetic DNA that can control cells' protein production, which could contibute to vaccine and drug development.
Why Do Some Vaccines Create Long-Lived Responses and Others Don’t?
A research team has shown in real time how long-lived plasma cells are stored in the bone marrow at around one single cell per hour for several weeks after immunization.
Long-Term Exposure to Air Pollution Undermines the Immune System
Inhaled pollutants can collect in the lymph nodes associated with the lung, accumulating over decades and weakening the immune cells' ability to fight off lung infections.
HIV Infection Leaves a "Memory" in Cells
New study reveals why comorbidities persist in people living with HIV, despite suppressing the virus through treatment.
“Unusual” Antibody Neutralizes Zika Virus Even at Miniscule Levels
Researchers have identified an "unusual" type of antibody that can neutralize the Zika virus, rendering it undetectable in preclinical models.